Cancer Policy: Pharmaceutical Safety
Springer International Publishing (Verlag)
978-3-319-43894-8 (ISBN)
Pharmacovigilance programs: Do they improve Cancer Drug Safety?.- Impact of Cost on the Safety of Cancer pharmaceuticals.- Assessing pharmaceutical safety in Geriatric Oncology.- Cancer co-Morbidity: Implications for Drug Safety.- Statistical aids to signal generation: Are they effective in Identifying Adverse Cancer Drug Reactions?.- Pharmacovigilance of alternative medications in the Cancer Setting.- Key elements in Adverse Drug Interaction Safety Signals: evaluation of individual case reports in oncology.- Biosimilars: Are they really safe? .- Natural Language processing: improving the identification and communication of Cancer Drug Safety.- The Drug Shortage Crisis in the United States: Impact on cancer pharmaceutical safety.- Anatomy of Risk Evaluation and Mitigation Strategies (REMS).- Cancer Drug Toxicity: Moving from patient to Survivor.
Erscheinungsdatum | 18.01.2019 |
---|---|
Reihe/Serie | Cancer Treatment and Research |
Zusatzinfo | V, 128 p. 1 illus. |
Verlagsort | Cham |
Sprache | englisch |
Maße | 155 x 235 mm |
Themenwelt | Medizin / Pharmazie ► Medizinische Fachgebiete ► Onkologie |
Medizin / Pharmazie ► Medizinische Fachgebiete ► Pharmakologie / Pharmakotherapie | |
Schlagworte | drug safety • Drug Safety and Pharmacovigilance • Health • Medicine • Oncology • Pharmaceutical • Policy • Toxicity |
ISBN-10 | 3-319-43894-8 / 3319438948 |
ISBN-13 | 978-3-319-43894-8 / 9783319438948 |
Zustand | Neuware |
Haben Sie eine Frage zum Produkt? |
aus dem Bereich